EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Downregulation of COX-2 expression in liver sinusoidal endothelial cell prevented the formation of liver sinusoidal microthrombi through the AKT/mTOR/TSP-1 axis

Shuaijie Qian, Can Gan, Chong Zhao, Wenting Dai, Xin Quan, Xu Guo, Linhao Zhang, Jinhang Gao, Chengwei Tang, Hao Wu

Pharmacological Research · 2026

DOI: 10.1016/j.phrs.2026.108356 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacological Research, 2026. Verfasst von Shuaijie Qian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Lab of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Cyclooxygenase 2, Endothelial Cells, Proto-Oncogene Proteins c-akt. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chengdu Science and Technology Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver sinusoidal microthrombosis (LST) is recognized as an initiating event in fibrogenesis and portal hypertension in chronic liver diseases. Liver sinusoidal endothelial cell (LSEC)-derived chemoattractants recruit neutrophils and macrophages, promoting LST in congestive hepatopathy (CH). However, the driving molecules from LSECs for LST remain unclear. This study aims to elucidate that LSECs inflammatory via cyclooxygenase-2 (COX-2) upregulation triggers metabolic reprogramming promoting thrombospondin-1 (TSP-1)-mediated LST and portal hypertension. A murine model of LST and portal hypertension was established by partial ligation of inferior vena cava (pIVCL). LST and portal hypertension were suppressed in both LSEC-specific COX-2 knockout mice (Ptgs2ΔLSEC) and celecoxib-treated wild-type mice induced by pIVCL. RNA sequencing of mouse liver tissue and untargeted metabolomics of human hepatic sinusoidal endothelial cells (HHSECs) revealed that COX-2 inhibition was concurrent with downregulation of the AKT/mTOR pathway, reduced lactate, and decreased TSP-1. In vitro, COX-2-derived prostaglandin E2 (PGE2) activated the AKT/mTOR pathway, driving glycolytic reprogramming and lactate production. In turn, the accumulation of lactate induced by COX-2 upregulation enhanced histone H3K9 lactylation, which transcriptionally upregulated Thbs1 (encoding TSP-1), thereby instigating a prothrombotic phenotype in LSECs. Collectively, this study uncovers a novel pathogenic axis in LST formation, where COX-2 drives a prothrombotic switch in LSECs via AKT/mTOR-mediated metabolic reprogramming and lactate-dependent epigenetic upregulation of TSP-1. Targeting LSEC COX-2 may represent a promising therapeutic strategy for mitigating LST and portal hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesCyclooxygenase 2Endothelial CellsProto-Oncogene Proteins c-aktLiverThrombospondin 1AnimalsDown-RegulationHumansMaleMice, KnockoutHypertension, PortalMice, Inbred C57BLMiceSignal Transduction

Stichwörter der Autor:innen

Cyclooxygenase-2Histone lactylationLactateLiver sinusoidal microthrombosisPortal hypertensionThrombospondin-1

Substanzen

TOR Serine-Threonine KinasesCyclooxygenase 2Proto-Oncogene Proteins c-aktThrombospondin 1mTOR protein, mousePtgs2 protein, mouseThbs1 protein, mouse

Autor:innen und Institutionen

  • Department of Gastroenterology, Lab of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Gastroenterology, Lab of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: shcqcdmed@163.com.
  • Department of Gastroenterology, Lab of Gastroenterology and Hepatology, West China Hospital, Sichuan University, Chengdu, China. Electronic address: hxxhwh@163.com.

Förderung

  • Chengdu Science and Technology Program
  • National Natural Science Foundation of China

Zitieren

APA

Qian, S., Gan, C., Zhao, C., Dai, W., Quan, X., Guo, X., Zhang, L., Gao, J., Tang, C., & Wu, H. (2026). Downregulation of COX-2 expression in liver sinusoidal endothelial cell prevented the formation of liver sinusoidal microthrombi through the AKT/mTOR/TSP-1 axis. Pharmacological Research. https://doi.org/10.1016/j.phrs.2026.108356

Vancouver

Qian S, Gan C, Zhao C, Dai W, Quan X, Guo X, et al. Downregulation of COX-2 expression in liver sinusoidal endothelial cell prevented the formation of liver sinusoidal microthrombi through the AKT/mTOR/TSP-1 axis. Pharmacological Research. 2026. doi:10.1016/j.phrs.2026.108356

BibTeX
@article{Qian2026,
  author = {Qian, Shuaijie and Gan, Can and Zhao, Chong and Dai, Wenting and Quan, Xin and Guo, Xu and Zhang, Linhao and Gao, Jinhang and Tang, Chengwei and Wu, Hao},
  title = {Downregulation of COX-2 expression in liver sinusoidal endothelial cell prevented the formation of liver sinusoidal microthrombi through the AKT/mTOR/TSP-1 axis},
  journal = {Pharmacological Research},
  year = {2026},
  doi = {10.1016/j.phrs.2026.108356}
}
Kostenlos starten →